BioSpace News Archive

Novavax, Inc. (Nasdaq: NVAX), today announced its submission to Swissmedic, the Swiss Agency for Therapeutic Products, for conditional marketing authorization (CMA) of NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant, for use in adults.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2021 financial results on Monday, February 28, 2022, after the close of the U.S. financial markets.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced preliminary results supporting the successful conclusion of its second Phase 1 trial (MB-105) in Poland evaluating Annamycin for the treatment of relapsed and refractory acute myeloid leukemia (AML).

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), today provided an update on PharmaCyte’s activities to lift the U.S. Food and Drug Administration’s (FDA) clinical hold on PharmaCyte’s treatment for locally advanced, inoperable pancreatic cancer (LAPC).

Altamira Therapeutics Ltd. announced completion of patient enrollment in Part B of the Phase 2 ‘TRAVERS’ clinical trial evaluating intranasal betahistine in acute vertigo.

Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink’s 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.

Hillstream BioPharma, Inc., a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, provided a business review along with key pipeline updates.

Net Medical is providing “Gold Standard PCR’ testing for Covid, ordinary flu, colds and related other upper respiratory infections to the people of New Mexico.

The global testosterone replacement therapy market is expected to be influenced by the rising awareness about the diseases itself.

Reprocessing of medical devices indicate the way toward cleaning, investigating, testing, disinfecting, and bundling of utilized and terminated medical devices.